Related Experiment Video
Updated: Feb 12, 2026

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
Published on: March 8, 2024
Fluid hydration to prevent post-ERCP pancreatitis in average- to high-risk patients receiving prophylactic rectal
Xavier J N M Smeets1, David W da Costa2, Paul Fockens3
1Department of Gastroenterology and Hepatology, Radboud University Medical Centre, PO 9101, 6500 HB, Nijmegen, The Netherlands. xavier.smeets@radboudumc.nl.
Insights
Vigorous hydration combined with rectal NSAIDs may reduce post-ERCP pancreatitis incidence in high-risk patients. This study investigates the effectiveness of this combination therapy for preventing post-ERCP pancreatitis.
Area of Science:
- Gastroenterology
- Clinical Trials
- Medical Interventions
Background:
- Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) is a common and potentially severe complication.
- Current evidence on periprocedural hydration for PEP prevention has methodological limitations.
- The added benefit and cost-effectiveness of hydration alongside prophylactic rectal non-steroidal anti-inflammatory drugs (NSAIDs) for PEP prevention remain uninvestigated.
Purpose of the Study:
- To evaluate if combination therapy of rectal NSAIDs and periprocedural hydration significantly reduces PEP incidence compared to rectal NSAIDs alone.
- To assess the impact on PEP severity, hydration-related complications, and cost-effectiveness.
Main Methods:
- The FLUYT trial is a multicenter, open-label, superiority randomized controlled trial involving 826 moderate- to high-risk patients.
- Patients received prophylactic rectal NSAIDs and were randomized to either a control group (limited hydration) or an intervention group (lactated Ringer's solution with a specific hydration schedule).
- Primary endpoint: PEP incidence. Secondary endpoints: PEP severity, hydration complications, cost-effectiveness.
Main Results:
- This section is not available in the provided abstract.
Conclusions:
- The FLUYT trial is designed with a robust hydration protocol, fluid selection, and sample size to effectively detect differences in PEP incidence.
- The trial aims to provide crucial evidence on the efficacy of combined hydration and NSAID therapy for PEP prevention.
Background:
Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) is the most common complication of ERCP and may run a severe course. Evidence suggests that vigorous periprocedural hydration can prevent PEP, but studies to date have significant methodological drawbacks. Importantly, evidence for its added value in patients already receiving prophylactic rectal non-steroidal anti-inflammatory drugs (NSAIDs) is lacking and the cost-effectiveness of the approach has not been investigated. We hypothesize that combination therapy of rectal NSAIDs and periprocedural hydration would significantly lower the incidence of post-ERCP pancreatitis compared to rectal NSAIDs alone in moderate- to high-risk patients undergoing ERCP.
Methods:
The FLUYT trial is a multicenter, parallel group, open label, superiority randomized controlled trial. A total of 826 moderate- to high-risk patients undergoing ERCP that receive prophylactic rectal NSAIDs will be randomized to a control group (no fluids or normal saline with a maximum of 1.5 mL/kg/h and 3 L/24 h) or intervention group (lactated Ringer's solution with 20 mL/kg over 60 min at start of ERCP, followed by 3 mL/kg/h for 8 h thereafter). The primary endpoint is the incidence of post-ERCP pancreatitis. Secondary endpoints include PEP severity, hydration-related complications, and cost-effectiveness.
Discussion:
The FLUYT trial design, including hydration schedule, fluid type, and sample size, maximize its power of identifying a potential difference in post-ERCP pancreatitis incidence in patients receiving prophylactic rectal NSAIDs.
Trial Registration:
EudraCT: 2015-000829-37 . Registered on 18 February 2015.
Isrctn:
13659155 . Registered on 18 May 2015.
More Related Videos
Related Concept Videos
Trial and Error and Algorithm
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Statistical Software for Data Analysis and Clinical Trials
Endoscopic Procedures V: ERCP
Patient...
Hydration of Cement

